Millennium Pharmaceuticals Inc: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	57
ISBN Number	not applicable
Product Code	DAT09413

Price

£265.00
approximately: $521 | €337

PRINT £265 ($521 | €337)

Order above formats by FAX

Summary

Introduction

Millennium Pharmaceuticals focuses on the development and commercialization of products for the treatment of oncology and inflammatory diseases. The company's lead product is Velcade, used in the treatment of multiple myeloma, and is also being developed for use in treating other cancers, including lymphoma and lung cancer.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Millennium Pharmaceuticals is engaged in developing and commercializing drugs and potential drugs for oncology and inflammatory diseases. The company markets one product, namely Velcade, for the treatment of multiple myeloma. The company is also focusing on opportunities to use Velcade in treating other cancers, including lymphoma and lung cancer.

The company's total revenues increased at a CAGR of 8% during 2002-2006, from $353 million to $487 million. This represents an absolute total growth of +$134 million for total revenues during the same period. It's major contributor to revenue growth during 2002-2006 was Velcade, whose sales increased at an absolute growth of +$220 million.

Millennium Pharmaceuticals's biggest contributor to sales growth out to 2010 will be the sales of Velcade. Revenues from Velcade are expected to increase at a CAGR of 15%, from $220 million in 2006 to $380 million in 2010. This represents an absolute growth of +$160 million, which is approximately 96.3% of total forecast growth out to 2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Discovery and Product Development
- Manufacturing
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Millennium Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Millennium Pharmaceuticals - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Millennium Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: Millennium Pharmaceuticals - Key Facts
- Table 2: Millennium Pharmaceuticals - Locations and Subsidiaries
- Table 3: Millennium Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Millennium Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: Millennium Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Millennium Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: Millennium Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Millennium Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Millennium Pharmaceuticals - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: Millennium Pharmaceuticals - Marketed Products
- Table 11: Millennium Pharmaceuticals - in-house Pipeline Products
- Table 12: Millennium Pharmaceuticals - Collaboration Pipeline Products
- Table 13: Millennium Pharmaceuticals - Historical Product Sales, 2002-2006 ($ Mn)
- Table 14: Millennium Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 15: Millennium Pharmaceuticals - Key Competitors
- Table 16: Millennium Pharmaceuticals - Key Suppliers
- Table 17: Millennium Pharmaceuticals - Key Shareholders
- Table 18: Millennium Pharmaceuticals - SWOT Analysis Summary
- Table 19: Millennium Pharmaceuticals - Value Chain Analysis
- Table 20: Millennium Pharmaceuticals - Scorecard
- Table 21: Millennium Pharmaceuticals - Key Employees
- Table 22: Millennium Pharmaceuticals - Financial and Operational Overview